24 May 2013
Keywords: mallinckrodt, files, mri, agent, usa, filed, new
Article | 17 March 1998
Mallinckrodt has filed a New Drug Application in the USA for Optimark, anew magnetic resonance imaging contrast agent. The company ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
23 May 2013
© 2013 thepharmaletter.com